Company intelligence / Profile preview

AccuraMed

Guangzhou, Guangdong, Chinaaccuramed.be ↗

Ownership: Private
Development stage: Commercial

Overview

AccuraMed provides advanced solutions for the detection and analysis of tissue biomarkers, specializing in the tumor immune microenvironment. Their offerings support both clinical diagnostics and basic research in oncology. They have established strong partnerships with leading academic institutions to advance innovation in immunodiagnostics[1][2].

Therapeutic areas: Oncology
Modalities: Diagnostic technology
Industry: Protein Biomarker Diagnostics

Partnerships

Chinese Academy of Sciences

Beyond the preview

Go deeper on AccuraMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AccuraMed.

Explore the full profile